Vice President Joe Biden, in a Rose Garden address announcing his decision to not run for president, called for a national commitment to end cancer—expressing that, were he to run and be elected, it would be a goal of his presidency.
Dear Editor,We are writing to clarify a few points in your Oct. 2 article, “CMS to Trim Spending on Diagnostic Lab Tests,” as it mistakenly intertwines two issues.
The Pershing Square Sohn Cancer Research Alliance is taking applications for its Prize for Young Investigators in Cancer Research.
Yesterday, two Medicare administrative contractors—National Government Services and Cahaba Government Benefit Administrators—released draft local coverage determinations for next generation sequencing in advanced lung cancer.
September 2015 PDF Lung Cancer Avastin Biosimilar Meets Phase III Endpoints, Demonstrating Clinical Equivalence Amgen and Allergan plc. announced positive top-line results from Avastin biosimilar candidate ABP 215, which met its primary and secondary endpoints in a phase III trial in advanced non-squamous non-small cell lung cancer. ABP 215 is being developed as a biosimilar […]
JOAQUIN ESPINOZA was named associate director of science at the Linda Crnic Institute for Down Syndrome at the University of Colorado Denver School of Medicine at the Anschutz Medical Campus (CU Anschutz).
EVELYN WHITLOCK named chief science officer of Patient-Centered Outcomes Research Institute.
JEFFREY MEDIN was named MACC (Midwest Athletes Against Childhood Cancer) Fund Endowed Professor at the department of pediatrics at the Medical College of Wisconsin.
PETER SCHULTZ was named CEO and STEVE KAY was named president of The Scripps Research Institute.
GILDA'S CLUB CHICAGO and other organizations across the country launched the It's About Time campaign, an initiative to raise awareness of metastatic breast cancer.
